UK Breast Cancer Group is a forum for Clinical and Medical Oncologists

David Dodwell

Back
Professor David Dodwell is a senior breast oncologist with a number of research and governance activities. He is the lead oncologist on the Sloane, NHS screening & National HQIP breast cancer audits.
David Dodwell

Professor Dodwell is Senior Research Fellow within the EBCTCG - a co-operative group with an international reputation for practice-changing meta-analyses. He is a member of steering groups for many ongoing UK trials in breast cancer and sits on the trial management committees for three trials and data management committee for two trials.

He is UK lead for the SACT project (UK chemotherapy database) and chairs the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England. This group has a current focus on the assessment of early chemotherapy mortality, outcomes following the use of CDF drugs, ascertainment and data quality, the treatment of older patients, outcomes in the context of BMI, and the variable uptake of chemotherapy according to socio-economic status, age, proximity to hospital and stage.